10-144 C.M.R. ch. 709, § 9.0 - SCREENING TEST PERFORMED
9.1 Screening for
CCHD shall be performed by pulse oximetry using equipment approved for neonatal
use by the FDA. See (http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm).
9.2 Screening is performed in the right hand
and either foot. Screening can occur concurrently or sequentially.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.